AORT Valuation

Artivion Inc

Add to Watchlist

Advanced Chart

43.320

-0.39(-0.892%)1D

Overview
Forecast
Valuation
Earnings

AORT Relative Valuation

AORT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AORT is overvalued; if below, it's undervalued.

Historical Valuation

Artivion Inc (AORT) is now in the Overvalued zone, suggesting that its current forward PS ratio of 4.49 is considered Overvalued compared with the five-year average of 120.68. The fair price of Artivion Inc (AORT) is between 22.57 to 32.83 according to relative valuation methord. Compared to the current price of 43.78 USD , Artivion Inc is Overvalued By 33.32%.

Relative Value

Fair Zone

22.57-32.83

Current Price：43.78

33.32%

Overvalued

185.45

Trailing

Forward

23.52

EV/EBITDA

Artivion Inc. (AORT) has a current EV/EBITDA of 23.52. The 5-year average EV/EBITDA is 21.02. The thresholds are as follows: Strongly Undervalued below 9.74, Undervalued between 9.74 and 15.38, Fairly Valued between 26.66 and 15.38, Overvalued between 26.66 and 32.29, and Strongly Overvalued above 32.29. The current Forward EV/EBITDA of 23.52 falls within the Historic Trend Line -Fairly Valued range.

56.53

EV/EBIT

Artivion Inc. (AORT) has a current EV/EBIT of 56.53. The 5-year average EV/EBIT is 102.25. The thresholds are as follows: Strongly Undervalued below -88.61, Undervalued between -88.61 and 6.82, Fairly Valued between 197.67 and 6.82, Overvalued between 197.67 and 293.10, and Strongly Overvalued above 293.10. The current Forward EV/EBIT of 56.53 falls within the Historic Trend Line -Fairly Valued range.

4.46

Artivion Inc. (AORT) has a current PS of 4.46. The 5-year average PS is 2.46. The thresholds are as follows: Strongly Undervalued below 1.14, Undervalued between 1.14 and 1.80, Fairly Valued between 3.12 and 1.80, Overvalued between 3.12 and 3.78, and Strongly Overvalued above 3.78. The current Forward PS of 4.46 falls within the Strongly Overvalued range.

67.08

P/OCF

Artivion Inc. (AORT) has a current P/OCF of 67.08. The 5-year average P/OCF is 23.15. The thresholds are as follows: Strongly Undervalued below -7.57, Undervalued between -7.57 and 7.79, Fairly Valued between 38.51 and 7.79, Overvalued between 38.51 and 53.87, and Strongly Overvalued above 53.87. The current Forward P/OCF of 67.08 falls within the Strongly Overvalued range.

0.00

P/FCF

Artivion Inc. (AORT) has a current P/FCF of 0.00. The 5-year average P/FCF is 7.28. The thresholds are as follows: Strongly Undervalued below -38.76, Undervalued between -38.76 and -15.74, Fairly Valued between 30.30 and -15.74, Overvalued between 30.30 and 53.32, and Strongly Overvalued above 53.32. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

Artivion Inc (AORT) has a current Price-to-Book (P/B) ratio of 4.90. Compared to its 3-year average P/B ratio of 2.97 , the current P/B ratio is approximately 65.37% higher. Relative to its 5-year average P/B ratio of 2.91, the current P/B ratio is about 68.23% higher. Artivion Inc (AORT) has a Forward Free Cash Flow (FCF) yield of approximately 0.37%. Compared to its 3-year average FCF yield of -0.38%, the current FCF yield is approximately -196.65% lower. Relative to its 5-year average FCF yield of -0.54% , the current FCF yield is about -169.05% lower.

4.86

P/B

Median3y

2.97

Median5y

2.91

0.37

FCF Yield

Median3y

-0.38

Median5y

-0.54

Competitors Valuation Multiple

The average P/S ratio for AORT's competitors is 3.74, providing a benchmark for relative valuation. Artivion Inc Corp (AORT) exhibits a P/S ratio of 4.46, which is 19.25% above the industry average. Given its robust revenue growth of 15.26%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

LeMaitre Vascular Inc

Procept Biorobotics Corp

Performance Decomposition

Market capitalization of AORT increased by 64.20% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -33.89 to -103.05.

The secondary factor is the Revenue Growth, contributed 15.26%to the performance.

Overall, the performance of AORT in the past 1 year is driven by P/E Change. Which is more unsustainable.

15.26%

98.02M → 112.97M

Revenue Growth

-155.09%

-2.16 → 1.19

Margin Expansion

204.03%

-33.89 → -103.05

P/E Change

64.20%